SkinHealth Systems Inc(SKIN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.51 | Insider Own | 38.63% | Shs Outstand | 6.5M | Perf Week | -9.32% |
| Market Cap | 0.07B | Forward P/E | - | EPS next Y | 68.25% | Insider Trans | - | Shs Float | 4.0M | Perf Month | -22.15% |
| Enterprise Value | 0.23B | PEG | - | EPS next Q | -1.33 | Inst Own | 51.49% | Short Float | 9.41% | Perf Quarter | -21.37% |
| Income | -0.03B | P/S | 0.23 | EPS this Y | -97.97% | Inst Trans | - | Short Ratio | 14.37 | Perf Half Y | -39.44% |
| Sales | 0.29B | P/B | 1.18 | EPS next 5Y | 35.72% | ROA | -5.72% | Short Interest | 0.38M | Perf YTD | -63.6% |
| Book/sh | 8.54 | P/C | 0.32 | EPS past 3/5Y | 11.04% 28.16% | ROE | -43.88% | 52W High | -70.92% ($34.80) | Perf Year | -65.34% |
| Cash/sh | 31.67 | P/FCF | 3.11 | Sales past 3/5Y | -6.32% 20.36% | ROIC | -9.01% | 52W Low | 2.33% ($9.89) | Perf 3Y | -88.85% |
| Dividend Est. | - | EV/EBITDA | 11.3 | EPS Y/Y TTM | -43.98% | Gross Margin | 66.37% | Volatility(W/M) | 5.94% 9.6% | Perf 5Y | -98.05% |
| Dividend TTM | - | EV/Sales | 0.78 | Sales Y/Y TTM | -6.45% | Oper. Margin | -1.47% | ATR (14) | 1.01 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.48 | EPS Q/Q | -169.35% | Profit Margin | -9.8% | RSI (14) | 35.45 | Recom | 3.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.76 | Sales Q/Q | -7.77% | SMA20 | -10.87% ($11.35) | Beta | 1.04 | Target Price | $15.67 |
| Payout | - | Debt/Eq | 6.61 | Earnings | 2026/11/5 | SMA50 | -19.7% ($12.6) | Rel Volume | 2.23 | Prev Close | $10.52 |
| Employees | 613 | LT Debt/Eq | 4.68 | EPS/Sales Surpr. | 20% -3.16% | SMA200 | -40.54% ($17.02) | Avg Volume(3M) | 0.03M | Price | $10.12 |
| IPO | 2020/11/24 | Option/Short | No/Yes | Trades | 393 | Volume | 58,362 | Change | -3.8% |
💆 Skin Health Systems (SKIN) is a global medical aesthetics company whose flagship brand is HydraFacial. It operates an integrated ecosystem of skin care devices, consumables, and treatment solutions, supplying beauty and medical channels worldwide—including the United States, Asia-Pacific, Europe, the Middle East, and Latin America.
Over the past 1 year, on the lower side
71% below its 1-year high.
Traded more than usual. That is 223% of its average volume.
Next earnings report: November 5
8 days to go.
SKIN has weak earnings and a weak balance sheet
Of every $100 in sales, $1.47 is lost.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -98.0% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $23. Peers typically go for $147. Compared with its own 1-year average, it is 645% pricier now.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -98.0%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 51.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #22 of 30 in the industry
Based on market cap of $66M.
YSG#21 Yatsen Holding Ltd ADR $152M PER - SKIN#22 SkinHealth Systems Inc $66M PER - 
SLSN#23 Solesence Inc $58M PER - 
GROV#24 Grove Collaborative Holdings Inc $45M PER - 
UG#25 United-Guardian Inc $31M PER 12.4 
FAQ
What kind of company is SKIN?
SKIN belongs to the Consumer Defensive sector and operates in the Household & Personal Products industry.
What is the market cap of SKIN?
The market cap of SKIN is approximately $66M, ranking 4,707 within its sector.
What is the 52-week high and low for SKIN?
SKIN has recorded a 52-week high of $34.80 and a low of $9.89.
